IBI3040 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

141 results for “IBI3040”

Trials

View all 124 →

Not yet recruiting

Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Participants

96 participants · First posted Aug 14, 2026

Not yet recruiting

Study of IBI343 in Subjects With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

25 participants · First posted Mar 20, 2024

A Study of IBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

5 participants · First posted Jan 10, 2024

Drugs

IBI3001

IBI3002

IBI324

News

View all 12 →

Innovent Unveils Next-Generation Obesity Pipeline at ADA 2026, Featuring Oral Daily and Weekly GLP-1 Candidates, Amylin Analog, and INHBE siRNA

Innovent's IBI343 Shows Promise in Advanced Pancreatic Cancer Trial

Innovent and SanegeneBio Initiate Phase 1 Trial of IBI3016 for Hypertension

Page 1 of 15